Previous studies have indicated that the activation of GPR30 can inhibit ferroptosis through the Nrf2/GPX4 signaling pathway, thereby ameliorating ischemia-reperfusion injury in the brain [19]. This evidence concerns the gene GPX4 and ischemia.